Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...
The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically ...
Although Mr Blake "wasn't fit and well enough to have chemotherapy", he received various treatments, including hormone ...
Philadelphia, November 12, 2024 – The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from ...
Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ETCompany ParticipantsBill Anderson - Chairman & CEOWolfgang Nickl ...
Evan Saugstad’s series discussing his journey with prostate cancer continues.
Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.
A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that combining pembrolizumab, ...
A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...
Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...